MedTrace Logo

Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia

NCT00762281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2012-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of hyperopia, when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.

Conditions

  • Hyperopia

Interventions

DEVICE

MEL 80 Hyperopic LASIK Treatment

Treatment of Hyperopic corrections ≤ +6.0 D with or without Astigmatism of +0.50 to +3.50 D and MRSE ≤ +6.50 D.

Sponsors & Collaborators

  • Carl Zeiss Meditec, Inc.

    lead INDUSTRY

Principal Investigators

  • Steven Dell, MD · Texan Eye Care

  • John Doane, MD · Discover Vision Centers

  • Richard Hoffman, MD · Fine, Hoffman, and Packer LLC

  • Howard Fine, MD · Fine, Hoffman, and Packer LLC

  • Mark Packer, MD · FIne, Hoffman, and Packer LLC

  • David Tanzer, MD · US Navy Refractive Surgery Center, San Diego, CA

  • Steve Schallhorn, MD · US Navy Refractive Surgery Center, San Diego, CA

  • John Vukich, MD · Davis Duehr Dean Eye Clinic

  • Jon Dishler, MD · Dishler Laser Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762281 on ClinicalTrials.gov